Rup Tandan is a Neurology physician affiliated with University of Vermont. OpenAlex indexes 134 publications with 7,581 citations (h-index 38); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 S Prospect St
Burlington, VT 054013456
Telephone
802-656-4588Registry record last updated 4 Oct 2013.
Clinical trials
- Dermatomyositis and Polymyositis Registry
Sponsor: Phoenix Neurological Associates, LTD
- A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
Sponsor: University of Vermont
- Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy
Sponsor: National Center for Research Resources (NCRR)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20258 payments
- Alexion Pharmaceuticals, Inc.Program year20251 payment
- Biogen, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Other nervous system drugs40%Radicava Ors100%Part D≥14 patientsBenzothiazole31.6%Riluzole100%Part D≥14 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1994–2010 per NIH RePORTER. The latest:
- CLINICAL TRIAL: THYMECTOMY IN NON-THYMOMATOUS MG PTS RECEIVING PREDINISONE
University of Vermont & St Agric College
FY2010$1,712M01RR000109 - CLINICAL TRIAL: PILOT TRIAL OF RITUXIMAB IN REFRACTORY MYASTHENIA GRAVIS
University of Vermont & St Agric College
FY2009$13,988M01RR000109 - CLINICAL TRIAL: EARLY TREATMENT OF ALS WITH NUTRITION AND NIPPV
University of Vermont & St Agric College
FY2009$6,527M01RR000109
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
David Krag, MD
University of Vermont
David Schneider, MD
University of Vermont
Robert Althoff, MD, PhD
University of Vermont
John Helzer, MD
University of Vermont
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”